You are reading:
Healthy Participants
|
The Immune Response Study Part 2
Healthy Participants
The Immune Response Study Part 2
Start date
Jul 22nd, 23rd
Renumeration
$12,585
2 x 4 night stays + 2 night stay, 6-11 appointments
Help Test a New Treatment for Inflammatory Bowel Disease (IBD)
This clinical study is evaluating a new antibody treatment for Inflammatory Bowel Disease (IBD), a condition that causes abdominal pain and diarrhoea. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.